https://www.selleckchem.com/pr....oducts/tulmimetostat
High-flow nasal cannula oxygenation (HFNC) and noninvasive positive-pressure ventilation (NPPV) possibly decrease tracheal reintubation rates better than conventional oxygen therapy (COT); however, few large-scale studies have compared HFNC and NPPV. We conducted a network meta-analysis (NMA) to compare the effectiveness of three post-extubation respiratory support devices (HFNC, NPPV, and COT) in reducing the mortality and reintubation risk. The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, and Ichushi database
Gefällt mir
Kommentar
Teilen
